Skip to main content
. 2017 Jan 21;16:106–114. doi: 10.1016/j.ebiom.2017.01.027

Table 4.

Multivariate analysis of predictors of progression-free survival (PFS) and overall survival (OS) in CR patients with DLBCL controlled by Revised International Prognostic Index (R-IPI).

Variable PFS
OS
RR 95% CI p value RR 95% CI p value
R-IPI
 Very good/good/poor 2.289 1.486 3.526 < 0.001 2.723 1.617 4.585 < 0.001
Double BCL-2/MYC expression
 Positive vs negative 2.266 1.293 3.973 0.004 2.140 1.098 4.172 0.025
BCRs related mutations
 Positive vs negative 2.192 1.209 3.973 0.010